Latest filing published 05 Jul 2019 for Insight Molecular Diagnostics Inc., €4.0M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Biotime Inc: trading record in brief
Biotime Inc is a declared insider at 2 companies; the most frequent names are Asterias Biotherapeutics, Inc. and Insight Molecular Diagnostics Inc. Between 1 October 2013 and 5 July 2019, the trades on record add up to 3 filings.
Sales make up the whole of the open-market record (1 sale, €4.0M). 2019 to date brings no purchases and 1 sale.
On 5 July 2019 came the latest disclosure, an open-market sale for €4.0M in Insight Molecular Diagnostics Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Biotime Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,250,000 shares@ US$2.00100.0% of flowCommon Stock, no par valueSEC:0001209191-19-041335:0
- 75,771 sharesSeries A Common StockSEC:0001140361-16-056186:0
- 21,773,340 shares@ US$2.34Series A Common StockSEC:0001209191-13-046829:0
3 of 3 declarations
